You just read:

Biscayne Neurotherapeutics Licenses Chinese Rights To Its Novel Antiepileptic Agent To Global Drug Development Centre (GDCC) China

News provided by

Biscayne Neurotherapeutics, Inc.

Mar 28, 2018, 07:00 ET